ArticleFrontiers in immunology2026
Immune cells with senescence-related transcriptional signatures orchestrate the inflammatory continuum in osteoarthritis synovium: a single-cell and machine learning study.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Synovitis is a key driver of osteoarthritis (OA), characterized by a chronic inflammatory microenvironment. However, the contribution of immune-cell senescence to synovial pathology and its therapeutic potential remains poorly understood. This study aims to map the senescent immune landscape and identify actionable targets for OA therapy. Methods: Single-cell RNA dataset (GSE152805) of OA synovium was used to identify immune subsets with senescence-related transcriptional signatures and subset-specific gene signatures. These gene signatures served as machine-learning features to train and validate diagnostic models in a combine dataset of 4 OA transcriptomic datasets (GSE55235, GSE55457, GSE82107, GSE169077) using Random Forest, Support Vector Machine, Gradient Boosting Machine, and eXtreme Gradient Boosting. Immunofluorescence staining and Western blotting of human synovial tissues validated macrophage-associated markers. Pseudotime trajectory and cell-cell communication analyses defined temporal dynamics and intercellular communication. Drug-gene interaction analysis and molecular docking were performed to assess therapeutic potential. Results: Macrophages, mast cells, and dendritic cells were identified as the immune populations with senescence-related transcriptional signatures. Pseudotime and communication analyses revealed a coordinated inflammatory continuum: macrophages initiated and sustained synovial inflammation, mast cells amplified intermediate inflammatory responses, and dendritic cells contributed to late-stage matrix remodeling. Machine-learning models identified hub biomarkers, with RHOB and PDK4 emerging as the macrophage-associated biomarkers with therapeutic potential. RHOB and PDK4 were markedly upregulated and colocalized with CD68 Conclusion: This study characterizes the transcriptomic landscape of senescence-related features in the OA synovial microenvironment. We identify RHOB and PDK4 as key macrophage-associated therapeutic targets, providing novel insights for immunomodulatory strategies in OA treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.